In NPC, our previous studies showed that both miR-9 and miR-124 functioned as tumor suppressors by targeting chemokine receptor-4 (CXCR4) and forkhead box Q1 (FOXQ1), respectively [37, 38]. Here, CXCR4 is linked to nasopharyngeal carcinoma.